These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22766619)

  • 21. Flu myths: dispelling the myths associated with live attenuated influenza vaccine.
    Tosh PK; Boyce TG; Poland GA
    Mayo Clin Proc; 2008 Jan; 83(1):77-84. PubMed ID: 18174020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
    Belshe RB; Ambrose CS; Yi T
    Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.
    Huber VC; McCullers JA
    J Infect Dis; 2006 Mar; 193(5):677-84. PubMed ID: 16453263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
    Kawai AT; Li L; Kulldorff M; Vellozzi C; Weintraub E; Baxter R; Belongia EA; Daley MF; Jacobsen SJ; Naleway A; Nordin JD; Lee GM
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):548-53. PubMed ID: 24497128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.
    Andersohn F; Bornemann R; Damm O; Frank M; Mittendorf T; Theidel U
    GMS Health Technol Assess; 2014; 10():Doc03. PubMed ID: 25371764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
    Ambrose CS; Wu X; Knuf M; Wutzler P
    Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing the safety of influenza vaccine in egg-allergic individuals.
    Greenhawt MJ
    Pediatr Ann; 2013 Jul; 42(7):122-7. PubMed ID: 23805959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
    King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
    J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination.
    Ambrose CS; Wu X; Belshe RB
    Pediatr Infect Dis J; 2010 Sep; 29(9):806-11. PubMed ID: 20458256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.
    Zhu W; Higgs BW; Morehouse C; Streicher K; Ambrose CS; Woo J; Kemble GW; Jallal B; Yao Y
    Vaccine; 2010 Apr; 28(16):2865-76. PubMed ID: 20153794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signals and trends of Guillain-Barré syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems.
    Lee H; Kim HJ; Choe YJ; Shin JY
    Vaccine; 2020 Jul; 38(34):5464-5473. PubMed ID: 32600907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
    Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
    Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults.
    Ambrose CS; Wu X
    Vaccine; 2013 Jan; 31(6):857-60. PubMed ID: 23261050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
    Ray GT; Lewis N; Goddard K; Ross P; Duffy J; DeStefano F; Baxter R; Klein NP
    Vaccine; 2017 May; 35(20):2668-2675. PubMed ID: 28404355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB; Edwards KM; Vesikari T; Black SV; Walker RE; Hultquist M; Kemble G; Connor EM;
    N Engl J Med; 2007 Feb; 356(7):685-96. PubMed ID: 17301299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
    Greene SK; Rett MD; Vellozzi C; Li L; Kulldorff M; Marcy SM; Daley MF; Belongia EA; Baxter R; Fireman BH; Jackson ML; Omer SB; Nordin JD; Jin R; Weintraub ES; Vijayadeva V; Lee GM
    PLoS One; 2013; 8(6):e67185. PubMed ID: 23840621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.